Premium
AMIGAS: A multicity, multicomponent cervical cancer prevention trial among Mexican American women
Author(s) -
Byrd Theresa L.,
Wilson Katherine M.,
Smith Judith Lee,
Coronado Gloria,
Ver Sally W.,
FernandezEsquer Maria Eugenia,
Thompson Beti,
Ortiz Melchor,
Lairson David,
Fernandez Maria E.
Publication year - 2012
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.27926
Subject(s) - medicine , pap test , papanicolaou stain , family medicine , cervical cancer , incidence (geometry) , ethnic group , health care , randomized controlled trial , intervention (counseling) , demography , gynecology , cervical cancer screening , gerontology , cancer , nursing , surgery , physics , sociology , anthropology , optics , economics , economic growth
BACKGROUND: Considerable efforts have been undertaken in the United States to reduce cervical cancer incidence and mortality by increasing screening; however, disparities in screening rates continue to exist among certain racial and ethnic minority groups. The objective of the current study was to determine the effectiveness of a lay health worker‐delivered intervention—AMIGAS ( Ayudando a las Mujeres con Informacion, Guia, y Amor para su Salud [helping women with information, guidance, and love for their health])—to increase Papanicolaou (Pap) test screening among 3 populations of women of Mexican origin. METHODS: Six hundred thirteen women of Mexican origin in 3 treatment sites were randomized among 4 study arms: the full AMIGAS program with a video and a flip chart (n = 151), the AMIGAS program without the video (n = 154), the AMIGAS program without the flip chart (n = 155), and a usual care control group (n = 153). Six months after enrollment, women were surveyed and reported whether or not they had been screened. RESULTS: Women in any of the intervention arms were statistically significantly more likely to report being screened than those in the usual care group in both an intent‐to‐treat analysis and a per‐protocol analysis. In the intent‐to‐treat analysis, 25% of women in the control group and 52% in the full AMIGAS program group reported having had Pap tests ( P < .001); in the per‐protocol analysis, the percentages were 29% and 62%, respectively ( P < .001). CONCLUSIONS: AMIGAS was effective in increasing Pap test screening among women of Mexican descent when used in a 1‐to‐1 setting. Future research should compare the 1‐on‐1 intervention with the group‐based intervention. Cancer 2013. © 2012 American Cancer Society.